Brief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Mon 22:57
BRIEF-Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing Oct 19 (Reuters) - Collegium Pharmaceutical, Inc. COLL.O:
COLLEGIUM PHARMACEUTICAL - CO AND GRÜNENTHAL ENTER SETTLEMENT AGREEMENT ON OCT 15, 2026 - SEC FILING
COLLEGIUM PHARMACEUTICAL - TERMINATES GRÜNENTHAL LICENSE AND CONSENT AGREEMENT FOR TERRITORY EFFECTIVE OCT 15, 2026 - SEC FILING
COLLEGIUM PHARMACEUTICAL - TO PAY GRÜNENTHAL $17 MILLION IN SETTLEMENT - SEC FILING
Source text: [ID:n0001104659-26-116876]
Further company coverage: COLL.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%